Bahar Tan Erentok

Bahar Tan Erentok currently serves as a Senior Manager of Regulatory Affairs, CMC at Corcept Therapeutics, overseeing the coordination of CMC sections for NDA, IND/IMPD/CTA filings for global Phase 1-3 trials. Previous roles include Manager of Regulatory Affairs, CMC at Myovant Sciences, where the focus was on NDA and MAA filings for various indications, achieving an NDA approval with special acknowledgment from the FDA. Early career experience spans positions in regulatory affairs, business development, and research across organizations such as PharmaCircle, Universitätsklinikum Ulm, Deva Pharmaceuticals, and the University of Arizona. Bahar holds a Master of Science in Molecular Medicine from Ulm University, as well as two Bachelor of Science degrees in Chemistry from the University of Arizona and Boğaziçi University, complemented by a certification in project management fundamentals from Stanford University.